• English
    • العربية
  • English 
    • English
    • العربية
  • Login
View Item 
  •   DSpace Home
  • Faculty of Pharmaceutical Sciences & Pharmaceutical Industries
  • Articles
  • View Item
  •   DSpace Home
  • Faculty of Pharmaceutical Sciences & Pharmaceutical Industries
  • Articles
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Lamotrigine loaded poly-ɛ-(d,l-lactide-co-caprolactone) nanoparticles as brain delivery system

View/Open
ammar2018.pdf (4.154Mb)
Date
2018
Author
Ammar, Hussein O.
Ghorab, Mahmoud M.
Mahmoud, Azza A.
Higazy, Iman M.
Metadata
Show full item record
Abstract
Management of epilepsy requires brain delivery therapy, therefore, this study was aimed to prepare lamotrigine loaded poly-ɛ-(d,l-lactide-co-caprolactone) (PLCL) nanoparticles using spontaneous emulsification solvent diffusion method. Nanoparticles for brain delivery required to have a particle size less than 200 nm, polydispesity index less than 0.2 and a sustained drug release properties. For such aim different factors were considered in preparing the nanoparticles as PLCL monomers' ratio, type of organic solvent used to prepare the nanoparticles, amount of PLCL and Pluronic® F127 in the nanoparticles. Prepared nanoparticles were characterized for their shape, particle size, polydispersity index, zeta potential, encapsulation efficiency, drug loading capacity, process yield and in-vitro drug release pattern. The in-vivo investigation for brain delivery of selected nanoparticles delivered by intravenous route was investigated in rats and compared to that for oral tablet. The obtained nanoparticles were spherical in shape. The amount of surfactant and PLCL affected the properties of the obtained nanoparticles. Using a mixture of organic solvent in preparing the nanoparticles improved its properties. The nanoparticles prepared using PLCL with monomers' ratio of 25: 75, had particle size value of 125 nm, polydispersity value of 0.184, zeta potential value of -39 mV and encapsulation efficiency of 99 %, was selected to study its efficacy to deliver the drug to the brain. The tested nanoparticles showed higher values of Tmax, Cmax, AUC, and MRT in homogenized rat brain, compared to oral lamotrigine tablet, while the bioavailability of the oral tablet was higher in rat plasma compared to that for the nanoparticles. This reflects that brain was the main distribution site for tested nanoparticles, and plasma was the main distribution site for oral tablets. This confirms the goal of the selected formulation as brain delivery nanoparticles.
URI
http://repository.fue.edu.eg/xmlui/handle/123456789/5133
Collections
  • Articles [227]

DSpace software copyright © 2002-2016  DuraSpace
Contact Us | Send Feedback
All rights reserved to 
Atmire NV
 

 

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

My Account

LoginRegister

DSpace software copyright © 2002-2016  DuraSpace
Contact Us | Send Feedback
All rights reserved to 
Atmire NV